Merck

MRK · Xetra · EUR

€136.90Change from previous close: +1.82%Absolute change: +€2.45

Close · October 2, 2026

At a glance

Revenue growth
+1.31%
2025 vs 2024
Net income growth
+6.64%
2025 vs 2024
Net margin
28.1%
2024: 26.7%

Financial data

Amounts in millions of EUR; per-share values in EUR; shares in millions.

Balance sheet · Quarterly
ItemQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Total assets52,68753,07051,52750,92747,35249,37351,59650,14249,87549,50448,49549,906
Current assets13,76914,16213,23012,87612,19612,41213,45013,92913,04712,82312,39313,566
Cash and equivalents1,9552,7432,7402,2511,1661,0052,5173,1612,6852,2201,9822,365
Short-term investments1,1681,031597673407615559699130264398218
Receivables4,9054,7794,7704,6944,8784,9784,8994,4644,8454,6814,9054,871
Inventory4,8864,7824,5624,5104,4684,5134,4844,4054,7144,7164,6374,971
Net property, plant and equipment10,05610,0449,9409,7769,6639,85410,0259,4159,4339,2149,0568,719
Goodwill18,45018,28017,93420,05517,34118,57519,10718,09318,32118,18117,84518,466
Other intangible assets7,5647,7667,6605,5795,5845,9816,3495,8456,2086,4816,5516,716
Long-term investments1,0279977729881,0341,0489641,0931,0651,071808993
Current liabilities8,1259,3499,0428,6379,8599,50211,29510,4639,9319,9398,6998,685
Accounts payable2,0682,1291,4221,9281,9602,0921,5021,9502,1222,0861,7702,244
Long-term debt10,69410,80210,2059,8085,6396,2436,3727,2357,1807,2988,8469,058
Total debt51,08646,67350,24539,96933,96833,48438,12134,98234,71731,142——
Total liabilities22,40023,25122,86721,92719,02419,47521,60721,74921,25921,43021,74021,611
Total equity (incl. minority)30,28729,81928,66029,00028,32829,89829,98928,39328,61628,07426,75528,295
Retained earnings24,93024,69324,01524,19823,34522,98022,42022,14521,37921,03120,63420,711
Minority interest11577.368.064.070.075.075.070.067.078.075.073.0